BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18209425)

  • 1. Diabetic nephropathy: improving prognosis.
    Friedman EA
    Saudi J Kidney Dis Transpl; 2002; 13(3):281-310. PubMed ID: 18209425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management choices in diabetic end-stage renal disease.
    Friedman EA
    Nephrol Dial Transplant; 1995; 10 Suppl 7():61-9. PubMed ID: 8570082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in diabetes: a substantive problem in provision of health care.
    Friedman EA
    Verh K Acad Geneeskd Belg; 1989; 51(2):81-149; discussion 149-51. PubMed ID: 2678807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products in diabetic nephropathy.
    Friedman EA
    Nephrol Dial Transplant; 1999; 14 Suppl 3():1-9. PubMed ID: 10382974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy in children and adolescents and its consequences in adults.
    Koulouridis E
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1367-77. PubMed ID: 11964036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CAPD (continuous ambulatory peritoneal dialysis) in diabetic nephropathy: overview and general practice in the Lainz Hospital since 1982].
    Auinger M
    Acta Med Austriaca; 1999; 26(5):154-8. PubMed ID: 11512192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
    Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
    Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy--prevention and treatment.
    Agarwal DK
    J Indian Med Assoc; 2002 Mar; 100(3):158-60, 162-3. PubMed ID: 12408275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study.
    Keane WF; Lyle PA;
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S22-5. PubMed ID: 12612946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.